242 related articles for article (PubMed ID: 29738549)
1. Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.
Clarisse D; Van Wesemael K; Tavernier J; Offner F; Beck IM; De Bosscher K
PLoS One; 2018; 13(5):e0197000. PubMed ID: 29738549
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a.
Robertson S; Allie-Reid F; Vanden Berghe W; Visser K; Binder A; Africander D; Vismer M; De Bosscher K; Hapgood J; Haegeman G; Louw A
J Biol Chem; 2010 Mar; 285(11):8061-75. PubMed ID: 20037160
[TBL] [Abstract][Full Text] [Related]
3. Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.
Zheng Y; Ishiguro H; Ide H; Inoue S; Kashiwagi E; Kawahara T; Jalalizadeh M; Reis LO; Miyamoto H
Mol Endocrinol; 2015 Oct; 29(10):1486-97. PubMed ID: 26322830
[TBL] [Abstract][Full Text] [Related]
4. Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.
Lesovaya E; Yemelyanov A; Kirsanov K; Popa A; Belitsky G; Yakubovskaya M; Gordon LI; Rosen ST; Budunova I
Cell Cycle; 2013 Jan; 12(1):133-44. PubMed ID: 23255118
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of non-steroid glucocorticoid receptor ligand CpdA on leukemia cell lines CEM and K562.
Lesovaya EA; Yemelyanov AY; Kirsanov KI; Yakubovskaya MG; Budunova IV
Biochemistry (Mosc); 2011 Nov; 76(11):1242-52. PubMed ID: 22117551
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of autophagy overcomes glucocorticoid resistance in lymphoid malignant cells.
Jiang L; Xu L; Xie J; Li S; Guan Y; Zhang Y; Hou Z; Guo T; Shu X; Wang C; Fan W; Si Y; Yang Y; Kang Z; Fang M; Liu Q
Cancer Biol Ther; 2015; 16(3):466-76. PubMed ID: 25778879
[TBL] [Abstract][Full Text] [Related]
7. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Medh RD; Saeed MF; Johnson BH; Thompson EB
Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia.
Ploner C; Schmidt S; Presul E; Renner K; Schröcksnadel K; Rainer J; Riml S; Kofler R
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):153-60. PubMed ID: 15860257
[TBL] [Abstract][Full Text] [Related]
10. Pyr3, a TRPC3 channel blocker, potentiates dexamethasone sensitivity and apoptosis in acute lymphoblastic leukemia cells by disturbing Ca(2+) signaling, mitochondrial membrane potential changes and reactive oxygen species production.
Abdoul-Azize S; Buquet C; Vannier JP; Dubus I
Eur J Pharmacol; 2016 Aug; 784():90-8. PubMed ID: 27179991
[TBL] [Abstract][Full Text] [Related]
11. Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer.
Chen Z; Lan X; Wu D; Sunkel B; Ye Z; Huang J; Liu Z; Clinton SK; Jin VX; Wang Q
Nat Commun; 2015 Sep; 6():8323. PubMed ID: 26374485
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells.
Clarisse D; Prekovic S; Vlummens P; Staessens E; Van Wesemael K; Thommis J; Fijalkowska D; Acke G; Zwart W; Beck IM; Offner F; De Bosscher K
Cell Mol Life Sci; 2023 Aug; 80(9):249. PubMed ID: 37578563
[TBL] [Abstract][Full Text] [Related]
13. Interplay of the inflammatory and stress systems in a hepatic cell line: interactions between glucocorticoid receptor agonists and interleukin-6.
Visser K; Smith C; Louw A
Endocrinology; 2010 Nov; 151(11):5279-93. PubMed ID: 20881254
[TBL] [Abstract][Full Text] [Related]
14. A New Indole Derivative, LWX-473, Overcomes Glucocorticoid Resistance in Jurkat Cells by Activating Mediators of Apoptosis.
Song J; Yang K; Gajendran B; Varier KM; Li W; Liu Q; Rao Q; Hang Y; Shen X; Liu S; Huang L; Xu M; Li Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):163. PubMed ID: 38682179
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia.
Evangelisti C; Cappellini A; Oliveira M; Fragoso R; Barata JT; Bertaina A; Locatelli F; Simioni C; Neri LM; Chiarini F; Lonetti A; Buontempo F; Orsini E; Pession A; Manzoli L; Martelli AM; Evangelisti C
J Cell Physiol; 2018 Mar; 233(3):1796-1811. PubMed ID: 28777460
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma.
Thomas AL; Coarfa C; Qian J; Wilkerson JJ; Rajapakshe K; Krett NL; Gunaratne PH; Rosen ST
Nucl Recept Signal; 2015; 13():e006. PubMed ID: 26715915
[TBL] [Abstract][Full Text] [Related]
17. A dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a mouse model of asthma.
Reber LL; Daubeuf F; Plantinga M; De Cauwer L; Gerlo S; Waelput W; Van Calenbergh S; Tavernier J; Haegeman G; Lambrecht BN; Frossard N; De Bosscher K
J Immunol; 2012 Apr; 188(7):3478-87. PubMed ID: 22393156
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma.
Patel GC; Millar JC; Clark AF
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1967-1978. PubMed ID: 31050723
[TBL] [Abstract][Full Text] [Related]
19. Eosinophil resistance to glucocorticoid-induced apoptosis is mediated by the transcription factor NFIL3.
Pazdrak K; Moon Y; Straub C; Stafford S; Kurosky A
Apoptosis; 2016 Apr; 21(4):421-31. PubMed ID: 26880402
[TBL] [Abstract][Full Text] [Related]
20. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
